{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Traws Pharma, Inc."},"Symbol":{"label":"Symbol","value":"TRAW"},"Address":{"label":"Address","value":"12 PENNS TRAIL, NEWTOWN, Pennsylvania, 18940, United States"},"Phone":{"label":"Phone","value":"+1 267 759-3680"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Onconova Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova's novel, proprietary multi-kinase inhibitor ON 123300 is currently in a dose-escalation and expansion Phase 1 trial in China, and an IND has been filed in the U.S. Its product candidate oral rigosertib is currently in a dose-escalation and expansion Phase 1 investigator-initiated study targeting patients with KRAS+ lung adenocarcinoma in combination with nivolumab."},"CompanyUrl":{"label":"Company Url","value":"https://www.onconova.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Charles David Pauza","title":"Chief Scientific Officer-Virology"},{"name":"Matthew Parris","title":"Vice President-Clinical Operations"},{"name":"Meena Arora","title":"Vice President-Global Medical Affairs"},{"name":"Nikolay Savchuk","title":"Chief Operating Officer & Director"},{"name":"Robert Redfield","title":"Chief Medical Officer"},{"name":"Victor Moyo","title":"Chief Medical Officer"},{"name":"Werner Cautreels","title":"Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}